Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Medical Devices | Videos
Production & Manufacturing
Manufacturing
Return to: PBR Home | Production & Manufacturing | Manufacturing | News
Search Refinements

Manufacturing News

View news from other Pharmaceutical sectors:
91-105 of 2230 results
Avacta opens two new facilities in Cambridge and Wetherby
Avacta Group, the developer of Affimer biotherapeutics and research reagents, has opened two new facilities, in Cambridge and Wetherby, Yorkshire.
Production & Manufacturing > Manufacturing > News
Endo decides to withdraw sNDA for OPANA ER
Endo International announced today that based on an August 11, 2016 discussion with the US Food and Drug Administration (FDA), it has decided to withdraw its supplemental New Drug Application (sNDA) relating to specific abuse deterrent labeling for OPANA ER without prejudice to re-filing.
Production & Manufacturing > Manufacturing > News
Jacobs wins contract for Novartis Pharma biotechnology center expansion in France
Jacobs Engineering Group has secured a contract to expand the Novartis Pharma Biotechnology Center in Huningue, France.
Production & Manufacturing > Manufacturing > News
Mylan completes Meda acquisition
Mylan has completed the settlement of its recommended public offer to the shareholders of Meda Aktiebolag (publ.) to tender all their shares in Meda to Mylan (the Offer).
Production & Manufacturing > Manufacturing > News
AbbVie files patent infringement suit over Amgen’s copy of Humira drug
By PBR Staff Writer
AbbVie has filed a patent infringement lawsuit, seeking to block Amgen from selling a copy of its Humira (adalimumab) rheumatoid arthritis drug.
Production & Manufacturing > Manufacturing > News
Jacobs wins contract for Alnylam's new manufacturing facility in Massachusetts
Jacobs Engineering Group has secured a contract to provide engineering services and procurement for Alnylam Pharmaceuticals’ new manufacturing facility in Norton, Massachusetts.
Production & Manufacturing > Manufacturing > News
EU clears Sanofi’s acquisition of Boehringer’s consumer health business
By PBR Staff Writer
French drug maker Sanofi has secured approval from the European Commission for its proposed acquisition of Boehringer Ingelheim’s consumer health business, subject to conditions.
Production & Manufacturing > Manufacturing > News
Avara to buy Astellas' US manufacturing subsidiary
Avara Pharmaceutical Services' subsidiary, Avara Norman Pharmaceutical Services has entered into an agreement under which Avara will acquire Astellas' wholly owned manufacturing subsidiary Astellas Pharma Technologies (APT), located in Norman, Oklahoma.
Production & Manufacturing > Manufacturing > News
Allergan sells global generics business to Teva Pharmaceuticals
Allergan has completed the divestiture of its global generic pharmaceuticals business to Teva Pharmaceutical Industries.
Production & Manufacturing > Manufacturing > News
Xbrane submits GMP approval application to Italy’s AIFA for production facility for Spherotide
By PBR Staff Writer
Xbrane Biopharma’s subsidiary Primm Pharma has submitted GMP approval application to the Italian Medicines Agency AIFA for its production facility for Spherotide located outside Naples, Italy.
Production & Manufacturing > Manufacturing > News
Oxford BioMedica secures UK MHRA approval to manufacture drugs at new facilities
By PBR Staff Writer
Oxford BioMedica has secured approvals from the UK Medicines and Healthcare products Regulatory Agency (MHRA) to manufacture bulk drug material for investigational medicinal products at its new facilities.
Production & Manufacturing > Manufacturing > News
GSK to invest £275m in three UK manufacturing sites
By PBR Staff Writer
GlaxoSmithKline (GSK) has unveiled plans to invest £275m in its UK manufacturing network, and said that it views the country as an attractive location for investment despite last month's vote to leave the European Union.
Production & Manufacturing > Manufacturing > News
Shangai Fosun to buy 86% stake in Gland Pharma for $1.26bn
By PBR Staff Writer
China's Shangai Fosun Pharmaceutical has agreed to acquire about 86% stake in Indian drugmaker Gland Pharma for $1.26bn.
Production & Manufacturing > Manufacturing > News
Hemispherx signs deal with Avrio Biopharmaceuticals for accelerated production of Ampligen
Hemispherx Biopharma has reached an agreement with Avrio Biopharmaceuticals ("Avrio"), Irvine California, to serve as an additional contract manufacturer of Hemispherx's experimental drug, Ampligen, also known by its generic name rintatolimod.
Production & Manufacturing > Manufacturing > News
Vectura initiates legal proceedings against GlaxoSmithKline
Vectura Group has received formal notification from GlaxoSmithKline ('GSK') that GSK does not wish to exercise the option to take a license to any additional patents under the patent licence and option agreement with Vectura dated 5th August 2010 for GSK's Breo Ellipta/Relvar Ellipta, Anoro Ellipta and Incruse Ellipta products (the Ellipta products).
Production & Manufacturing > Manufacturing > News
91-105 of 2230 results